Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.7K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.7K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

3.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

11.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.6K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.2K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

5.1K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Bone Remodeling01:40

Bone Remodeling

40.1K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Improved Brain-Penetrating Nanoformulation of the VIPR2 Antagonist Peptide KS-133 for Treating Cognitive Impairment in Schizophrenia.

Biological & pharmaceutical bulletin·2026
Same author

Neuropathological and Molecular Features Associated With a Heterozygous DNAJC7 Mutation in Amyotrophic Lateral Sclerosis.

Neuropathology and applied neurobiology·2026
Same author

Class 2, Stage A Cemental Tear Mimicking Apical Periodontitis: A Case Report.

Journal of endodontics·2026
Same author

A subclade-associated genomic deletion encompassing vraDEH confers increased susceptibility to nisin A and bacitracin in Staphylococcus aureus CC121.

Scientific reports·2026
Same author

Raman signatures of <i>Cnm</i>-positive <i>Streptococcus mutans</i>: III, clinical validation.

Frontiers in microbiology·2026
Same author

Association between an inpatient oral self-care promotion programme and hospital-acquired infections: a propensity score-matched cohort study.

The Journal of hospital infection·2026

Related Experiment Video

Updated: Dec 26, 2025

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

8.3K

Optineurin regulates osteoblastogenesis through STAT1.

Noriyoshi Mizuno1, Tomoyuki Iwata1, Ryosuke Ohsawa2

  • 1Department of Periodontal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8553, Japan.

Biochemical and Biophysical Research Communications
|March 16, 2020
PubMed
Summary

Optineurin (OPTN) regulates bone metabolism by controlling both osteoclast and osteoblast differentiation. This study reveals OPTN

Keywords:
OPTNOsteoblastOsteoclastRUNX2STAT1

More Related Videos

Author Spotlight: Comparing Alveolar and Long Bone Remodeling to Explore OTM Model Potential
05:25

Author Spotlight: Comparing Alveolar and Long Bone Remodeling to Explore OTM Model Potential

Published on: July 21, 2023

1.8K
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

4.9K

Related Experiment Videos

Last Updated: Dec 26, 2025

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

8.3K
Author Spotlight: Comparing Alveolar and Long Bone Remodeling to Explore OTM Model Potential
05:25

Author Spotlight: Comparing Alveolar and Long Bone Remodeling to Explore OTM Model Potential

Published on: July 21, 2023

1.8K
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

4.9K

Area of Science:

  • Bone Biology
  • Cellular Metabolism
  • Molecular Genetics

Background:

  • Bone metabolism relies on a balance between osteoclast resorption and osteoblast formation.
  • Optineurin (OPTN) is known for roles in glaucoma and ALS, with recent links to osteoclast regulation.
  • The specific role of OPTN in osteoblast function remains largely uncharacterized.

Purpose of the Study:

  • To investigate the role of Optineurin (OPTN) in regulating both osteoblast and osteoclast differentiation.
  • To elucidate the molecular mechanisms by which OPTN influences bone metabolism.

Main Methods:

  • Analysis of osteoblastogenesis and osteoclastogenesis parameters in Optn knockout (Optn-/-) mice.
  • Assessment of alkaline phosphatase activity and mineralized nodule formation in osteoblasts.
  • Investigation of OPTN's interaction with STAT1 and its effect on RUNX2 nuclear localization.

Main Results:

  • Osteoblasts from Optn-/- mice exhibited impaired alkaline phosphatase activity and defective mineralized nodule formation.
  • Optn-/- osteoblasts were unable to adequately support osteoclast differentiation.
  • OPTN was found to bind STAT1, modulating STAT1 levels and influencing RUNX2 nuclear translocation in osteoblasts.

Conclusions:

  • OPTN plays a crucial role in regulating osteoblast differentiation and function.
  • OPTN is essential for maintaining normal bone metabolism by influencing both osteoblasts and osteoclasts.
  • OPTN mediates RUNX2 nuclear translocation via STAT1, highlighting a novel molecular pathway in bone biology.